Log In
BCIQ
Print this Print this
 

MER 102

  Manage Alerts
Collapse Summary General Information
Company Merrion Pharmaceuticals plc
DescriptionOral low molecular weight heparin (LMWH)
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentPreclinical
Standard IndicationDeep vein thrombosis (DVT)
Indication DetailsTreat deep vein thrombosis (DVT)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today